Cargando…

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults

The SARS-CoV-2 Omicron variant has more than 15 mutations in the receptor binding domain of the Spike protein enabling increased transmissibility and viral escape from antibodies in vaccinated individuals. It is unclear how vaccine immunity protects against Omicron infection. Here we show that vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kared, Hassen, Wolf, Asia-Sophia, Alirezaylavasani, Amin, Ravussin, Anthony, Solum, Guri, Tran, Trung The, Lund-Johansen, Fridtjof, Vaage, John Torgils, Nissen-Meyer, Lise Sofie, Nygaard, Unni C., Hungnes, Olav, Robertson, Anna H., Næss, Lisbeth Meyer, Trogstad, Lill, Magnus, Per, Munthe, Ludvig A., Mjaaland, Siri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293966/ https://www.ncbi.nlm.nih.gov/pubmed/35851055 http://dx.doi.org/10.1038/s41467-022-31888-y

Ejemplares similares

Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort study
por: Ravussin, Anthony, et al.
Publicado: (2023)

T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
por: Wolf, Asia-Sophia, et al.
Publicado: (2023)

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self‐reported severity and duration of illness
por: Tunheim, Gro, et al.
Publicado: (2019)

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023)

Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
por: Jyssum, Ingrid, et al.
Publicado: (2022)

Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study
por: Laake, Ida, et al.
Publicado: (2018)

Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy
por: Savic, Miloje, et al.
Publicado: (2017)

Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study
por: Hovd, Markus, et al.
Publicado: (2023)

Detection of anti‐NS1 antibodies after pandemic influenza exposure: Evaluation of a serological method for distinguishing H1N1pdm09 infected from vaccinated cases
por: Robertson, Anna Hayman, et al.
Publicado: (2020)

Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study
por: Trogstad, Lill, et al.
Publicado: (2021)

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
por: Juvet, Lene Kristine, et al.
Publicado: (2021)

Robust spike-specific CD4(+) and CD8(+) T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
por: Federico, Lorenzo, et al.
Publicado: (2023)

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
por: Tran, Trung The, et al.
Publicado: (2022)

Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
por: Tran, Trung The, et al.
Publicado: (2023)

Prevalence of antibodies against SARS‐CoV‐2 in the Norwegian population, August 2021
por: Tunheim, Gro, et al.
Publicado: (2022)

Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic
por: Tunheim, Gro, et al.
Publicado: (2021)

Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
por: König, Marton, et al.
Publicado: (2022)

The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study
por: Christensen, Ingrid Egeland, et al.
Publicado: (2022)

Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
por: Holm, Sverre, et al.
Publicado: (2021)

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
por: Syversen, Silje W., et al.
Publicado: (2022)

Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in Norway
por: Caspersen, Ida Henriette, et al.
Publicado: (2023)

Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women
por: Blix, Kristine, et al.
Publicado: (2023)

Sa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY
por: Joergensen, Kristin K., et al.
Publicado: (2022)

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
por: König, Marton, et al.
Publicado: (2023)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
por: Søraas, Arne, et al.
Publicado: (2022)

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
por: Syversen, Silje Watterdal, et al.
Publicado: (2022)

Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort
por: Laake, Ida, et al.
Publicado: (2022)

Rituximab‐treated patients with lymphoma develop strong CD8 T‐cell responses following COVID‐19 vaccination
por: Riise, Jon, et al.
Publicado: (2022)

Reduced polyfunctional T cells and increased cellular activation markers in adult allergy patients reporting adverse reactions to food
por: Sonnet, Friederike, et al.
Publicado: (2020)

Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence
por: Federico, Lorenzo, et al.
Publicado: (2023)

Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort study
por: Gunnes, Nina, et al.
Publicado: (2020)

Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway
por: Ghaderi, Sara, et al.
Publicado: (2019)

Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort
por: Caspersen, Ida Henriette, et al.
Publicado: (2022)

Febrile seizures after 2009 influenza A (H1N1) vaccination and infection: a nationwide registry-based study
por: Bakken, Inger Johanne, et al.
Publicado: (2015)

Paired opposing leukocyte receptors recognizing rapidly evolving ligands are subject to homogenization of their ligand binding domains
por: Fossum, Sigbjørn, et al.
Publicado: (2011)

Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012
por: Bakken, Inger Johanne, et al.
Publicado: (2014)

Covid-19 vaccines and menstrual changes
por: Trogstad, Lill, et al.
Publicado: (2022)

Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
por: Jorgensen, Kristin, et al.
Publicado: (2022)

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
por: Bjørlykke, Kristin H, et al.
Publicado: (2023)

Current tobacco use and SARS-CoV-2 infection in two Norwegian population-based cohorts
por: Caspersen, Ida Henriette, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kg2qmupk69b98kjq82lbd45osv